-+ 0.00%
-+ 0.00%
-+ 0.00%

First Patient Enrolled in Phase 2 CERE-CALM Clinical Trial

ASX·10/28/2026 22:43:46

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.